ERBB2 and breast cancer: The Western blot analysis demonstrates that PTXNR-TTZ activates the effector caspase proteins in HER2 positive breast cancer cells, and downregulates the anti-apoptotic XIAP facilitating caspase-dependent apoptosis followed by the cell cycle arrest in the G2/M phase.